Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2020

May 8, 2020

30016_dirs_2020-05-08_eead122d-a6ec-4188-bb60-ff04e9368111.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-05-06

Reporting Person: SZOSTAK M ANNE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-06 Common Stock G 6717 Disposed 0 Indirect
2020-05-06 Common Stock G 584 Disposed 0 Direct
2020-05-06 Common Stock G 7301 Acquired 10217 Indirect
2020-05-06 Common Stock G 10217 Disposed 0 Indirect
2020-05-06 Common Stock G 10217 Acquired 10217 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-06 Deferred Stock Unit $ A 370 Acquired Common Stock (370) Direct
2020-05-06 Non-Qualified Stock Option (right-to-buy) $283.59 A 1279 Acquired 2030-05-05 Common Stock (1279) Direct

Footnotes

F1: The reporting person is the settlor of the M. Anne Szostak Trust ("Trust"), the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.

F2: The reporting person is the settlor and trustee of the 2020 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

F3: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F4: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier.

F5: Not applicable.